CytomX Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Three Years
CytomX Therapeutics, Inc. (CTMX) had Operating Leases, Future Minimum Payments, Due in Three Years of $5.13 million as of 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-02-27
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $5.13M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $4.99M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $4.86M.
- 2017-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $4.51M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2018-12-31 | $5.13M 10-K · filed 2019-02-27 |
| 2017-12-31 | $4.99M 10-K · filed 2018-03-07 |
| 2017-09-30 | $4.86M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $4.51M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $4.51M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $4.51M 10-K · filed 2017-03-02 |
| 2016-09-30 | $4.37M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $4.37M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $4.37M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $5.27M 10-K · filed 2016-03-07 |
| 2015-09-30 | $864.00K 10-Q · filed 2015-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |